Catch-22: Carotid stenting is safe and effective (Food and Drug Administration) but is it reasonable and necessary (Centers for Medicare and Medicaid Services)?
Christopher J
CJ
White
Michael R
MR
Jaff
D017130:Angioplasty / Q000009:adverse effects / Q000191:economics / Q000295:instrumentation*; D058070:Asymptomatic Diseases; D002340:Carotid Artery Diseases / Q000150:complications / Q000191:economics / Q000628:therapy*; D014487:Centers for Medicare and Medicaid Services, U.S. / Q000191:economics; D003362:Cost-Benefit Analysis; D004608:Eligibility Determination; D019317:Evidence-Based Medicine; D017048:Health Care Costs; D015276:Health Care Rationing; D006801:Humans; D007349:Insurance, Health, Reimbursement; D010043:Outcome and Process Assessment, Health Care / Q000191:economics; D061214:Patient Safety; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents / Q000191:economics; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration